510(k) Report

510(k) · Cleared

Cleared

Pharmacia Cap System Ige Feia, Model 10-9395-01

K991945510(k) TraditionalCleared Jul 28, 199949-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pharmacia & Upjohn Co. · DGC Ige, Antigen, Antiserum, Control

Cleared on Jul 28, 1999 after a 49-day review. The FDA summary names its predicate without a number. 1 later device descends from it.

Decided
Jul 28, 1999
Review
49 days
Class
Class II
Product code
DGC
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared1995200020052010201520202025
  1. This deviceK991945 Pharmacia Cap System Ige Feia, Model 10-9395-01Pharmacia & Upjohn Co. · 1999
  2. Descendant · cites it directly · 0 of its ownK032251 Immunetech Total Ige SystemImmunetech Corporation · 2003

Most influential descendants

Showing 1 of 1 · See all
  • K032251Immunetech Total Ige SystemImmunetech Corporation · 2003 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K991945Pharmacia Cap System Ige Feia, Model 10-9395-01Pharmacia & Upjohn Co.1999—
+1K032251Immunetech Total Ige SystemImmunetech Corporation2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
FIG. 1 — Lineage of K991945, 1999–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DGC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DGC device

  1. #1 K231151 Kenota 1 Total IgE; Kenota 1 (instrument)score 8.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Pharmacia CAP System IgE FEIA
Named without a submission number
—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K032251Immunetech Total Ige SystemImmunetech Corporation20030

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K032251 (Immunetech Corporation, 2003) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DGC devices

DGC Ige, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DGC

1in 2024

2007: 12014: 12016: 12020: 12022: 12023: 12024: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DGC

Too few DGC 510(k)s in any year since 2007 to give a median.

Recalls per year · DGC

1in 2016

2009: 12016: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DGC

2in 2021

2008: 22009: 52010: 122011: 132013: 12014: 12015: 22016: 22021: 2
2007high 13 (2011) · low 0 (2007)2025

MAUDE reports naming product code DGC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—02
20090—15
20100—012
20110—013
20120—00
20130—01
20141—01
20150—02
20161—12
20170—00
20180—00
20190—00
20201—00
20210—02
20221—00
20231—00
20241—00
20250—00
20260—0—

What is it indicated for?

Pharmacia CAP System IgE FEIA is an in vitro test system for the guantitative measurement of circulating total IgE in human blood samples.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991945: Pharmacia Cap System Ige Feia, Model 10-9395-01.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K991945

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026